Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis
M. Mcelroy (Edinburgh, United Kingdom), J. Baily (Edinburgh, United Kingdom), O. Peris Serrano (Edinburgh, United Kingdom), A. Marsden (Edinburgh, United Kingdom), M. Briggs (Harlow, United Kingdom), I. Love (Edinburgh, United Kingdom), S. Madden (Edinburgh, United Kingdom), S. Gandi (Edinburgh, United Kingdom), M. Whitmarsh (Harlow, United Kingdom), A. Young (Harlow, United Kingdom)
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Session: New mechanistic insights into pulmonary fibrosis
Session type: Thematic Poster
Number: 2422
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Mcelroy (Edinburgh, United Kingdom), J. Baily (Edinburgh, United Kingdom), O. Peris Serrano (Edinburgh, United Kingdom), A. Marsden (Edinburgh, United Kingdom), M. Briggs (Harlow, United Kingdom), I. Love (Edinburgh, United Kingdom), S. Madden (Edinburgh, United Kingdom), S. Gandi (Edinburgh, United Kingdom), M. Whitmarsh (Harlow, United Kingdom), A. Young (Harlow, United Kingdom). Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis. 2422
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: